US EditionPublished • loading... • Updated
BrioHealth Celebrates 100th BrioVAD® System Implant Milestone
The 100th implant milestone reflects growing confidence in the BrioVAD System's design to improve mechanical circulatory support for advanced heart failure patients.
- On March 17, 2026, BrioHealth Solutions announced the implantation of its 100th BrioVAD System at 34 U.S. INNOVATE Trial locations, as reported from Burlington, Massachusetts.
- The BrioVAD System is an investigational device limited by U.S. federal law to use in the INNOVATE Trial, and program expansion at major U.S. cardiac centers underpins ongoing clinical investigations.
- Through clinical training and technical support, hospital partners across the U.S. helped achieve 100 BrioVAD implants in the INNOVATE Trial, as CEO Chen Chen stated.
- Leadership framed the milestone as advancing the VAD field, with Francis D. Pagani, M.D., Ph.D. calling it significant for the clinical community and patients, and Chen Chen, Ph.D. noting ongoing expansion and next steps toward commercial approval.
- Framed within the company's goals, the BrioVAD System positions itself as a significant advance in heart-failure treatment, reflecting BrioHealth's founding mission to restore and enhance patients' lives in the broader mechanical circulatory support field.
Insights by Ground AI
21 Articles
21 Articles
Coverage Details
Total News Sources21
Leaning Left4Leaning Right2Center6Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 33%
C 50%
R 17%
Factuality
To view factuality data please Upgrade to Premium
